Leukemia Research
Volume 28, Issue 12 , Pages 1273-1280, December 2004

Histopathologic verification of acute leukemia (AL) in a cohort of 463 post-Chernobyl patients from Belarus, Russia and Ukraine

  • Philip L. McCarthy Jr.

      Affiliations

    • Department of Medicine, Blood and Marrow Transplant Section, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 716 845 8707; fax: +1 716 845 3272.
  • ,
  • Ora Paltiel

      Affiliations

    • Department of Social Medicine, Hadassah Medical Organization, Keriyat Hadassah, P.O. Box 12000, Jerusalem 91120, Israel
  • ,
  • Elena Maslova

      Affiliations

    • Data Coordination Office, International Consortium for Research on the Health Effects of Radiation, Russian Federation, Pogodinskaya 8, Building 2, First Floor, Moscow 12657, Russia
  • ,
  • Sergei Kulikov

      Affiliations

    • Data Coordination Office, International Consortium for Research on the Health Effects of Radiation, Russian Federation, Pogodinskaya 8, Building 2, First Floor, Moscow 12657, Russia
    • National Center for Hematology, Novozikovsky, pr. 4a, Moscow 125167, Russia
  • ,
  • Theresa Hahn

      Affiliations

    • Department of Medicine, Blood and Marrow Transplant Section, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
  • ,
  • Kenneth J. Kopecky

      Affiliations

    • Southwest Oncology Group Statistical Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M3-C102, P.O. Box 19024, Seattle, WA 98109-1024, USA
  • ,
  • Vera Drozdova

      Affiliations

    • Institute of Haematology and Transfusiology, M. Berlinskogo Street, 12, Kiev 01060, Ukraine
  • ,
  • Natalya Shmatina

      Affiliations

    • Haematology and Transplantology Center, Number 9 Hospital, Semashko Street, 8, Minsk 220089, Belarus
  • ,
  • Ludmilla Tichonova

      Affiliations

    • Data Coordination Office, International Consortium for Research on the Health Effects of Radiation, Russian Federation, Pogodinskaya 8, Building 2, First Floor, Moscow 12657, Russia
  • ,
  • Jack Van Hoff

      Affiliations

    • Department of Pediatrics, Yale University School of Medicine, Division of Hematology and Oncology, 333 Cedar St. LMP 4087, P.O. Box 208064, New Haven, CT 06520-8064, USA
  • ,
  • Inna Gavrilova

      Affiliations

    • Haematology and Transplantology Center, Number 9 Hospital, Semashko Street, 8, Minsk 220089, Belarus
  • ,
  • Howard Weinstein

      Affiliations

    • Chief, Pediatric Hematology-Oncology, Massachusetts General Hospital for Children, 55 Fruit St. Ellison 325, Boston, MA 02114-2696, USA

Received 2 October 2003; accepted 14 April 2004.

Abstract 

Seven morphologists examined 382 slide and 82 non-slide, post-Chernobyl pediatric acute leukemia (AL) cases in radiation-exposed areas of Belarus, Russia and Ukraine; part of a case-control study by the International Consortium for Research on the Health Effects of Radiation. Among the slide cases, 99% were confirmed as AL: 92% acute lymphoid leukemia (ALL) and 86% acute myeloid leukemia (AMD demonstrating the utility of FAB classification for distinguishing ALL and AML. Among the non-slide cases, 79% were confirmed as AL: 84% ALL, and 71% AML. This study affirms AL diagnostic accuracy during a time of social upheaval in the former Soviet Union.

Abbreviations:  AL, acute leukemia, ALL, acute lymphoid leukemia, ALLU, acute lymphoid leukemia, unclassified, ALU, acute leukemia, unclassified, AML, acute myeloid leukemia, AMLU, acute myeloid leukemia, unclassified, CML, chronic myeloid leukemia, FAB, French–American–British, FSU, former Soviet Union, GIMEMA, Gruppo Italiano Malattie Ematologiche dell’Adulto, ICRHER, International Consortium for Research on the Health Effects of Radiation, K, kappa statistic, L1, ALL FAB subtype L1, L2, ALL FAB subtype L2, L3, ALL FAB subtype L3, LDWG, Leukemia Diagnostic Working Group, M0, AML FAB subtype M0, Ml, AML FAB subtype Ml, M2, AML FAB subtype M2, M3, AML FAB subtype M3, M4, AML FAB subtype M4, M5, AML FAB subtype M5, M6, AML FAB subtype M6, M7, AML FAB subtype M7, MDS, myelodysplastic syndrome, Other, no diagnosis or not leukemia, Pa, percent actual agreement, Pc, percent based on chance, PAS, periodic Acid Schiff

Keywords:  Leukemia Diagnostic Working Group, Histopathology, FAB classification

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(04)00176-6

doi:10.1016/j.leukres.2004.04.008

Leukemia Research
Volume 28, Issue 12 , Pages 1273-1280, December 2004